149 related articles for article (PubMed ID: 8854013)
1. The replacement of water with deuterium oxide significantly improves the thermal stability of the oral poliovirus vaccine.
Crainic R; Wu R; Otelea D; Georgescu MM; Delpeyroux F; Guillot S; Balanant J; Tardy-Panit M
Dev Biol Stand; 1996; 87():161-6. PubMed ID: 8854013
[TBL] [Abstract][Full Text] [Related]
2. Regulatory considerations for new stabilised poliovaccines.
Milstien JB; Lemon S
Dev Biol Stand; 1996; 87():181-9. PubMed ID: 8854016
[TBL] [Abstract][Full Text] [Related]
3. Thermostability of poliovirus and measles vaccines.
Melnick JL
Dev Biol Stand; 1996; 87():155-60. PubMed ID: 8854012
[TBL] [Abstract][Full Text] [Related]
4. Stabilisation of poliovirus with pirodavir.
Rombaut B; Andries K; Boeyé A
Dev Biol Stand; 1996; 87():173-80. PubMed ID: 8854015
[TBL] [Abstract][Full Text] [Related]
5. Stabilising oral poliovaccine at high ambient temperatures.
Newman JF; Tirrell S; Ullman C; Piatti PG; Brown F
Dev Biol Stand; 1996; 87():103-11. PubMed ID: 8854007
[TBL] [Abstract][Full Text] [Related]
6. Effects of hydrostatic pressure on the stability and thermostability of poliovirus: a new method for vaccine preservation.
Ferreira E; Mendes YS; Silva JL; Galler R; Oliveira AC; Freire MS; Gaspar LP
Vaccine; 2009 Aug; 27(39):5332-7. PubMed ID: 19616496
[TBL] [Abstract][Full Text] [Related]
7. Elucidating mechanisms of thermostabilization of poliovirus by D2O and MgCl2.
Chen CH; Wu R; Roth LG; Guillot S; Crainic R
Arch Biochem Biophys; 1997 Jun; 342(1):108-16. PubMed ID: 9185619
[TBL] [Abstract][Full Text] [Related]
8. Capsid and RNA stabilisation of the oral polio vaccine.
Verheyden B; Andries K; Rombaut B
Vaccine; 2001 Feb; 19(15-16):1899-905. PubMed ID: 11228359
[TBL] [Abstract][Full Text] [Related]
9. Thermostabilization of live virus vaccines by heavy water (D2O).
Wu R; Georgescu MM; Delpeyroux F; Guillot S; Balanant J; Simpson K; Crainic R
Vaccine; 1995 Aug; 13(12):1058-63. PubMed ID: 7491812
[TBL] [Abstract][Full Text] [Related]
10. Studies on the loss of infectivity of live type 3 poliovaccine on storage.
Pipkin PA; Minor PD
Biologicals; 1998 Mar; 26(1):17-23. PubMed ID: 9637745
[TBL] [Abstract][Full Text] [Related]
11. Development of a more thermostable poliovirus vaccine.
Milstien JB; Lemon SM; Wright PF
J Infect Dis; 1997 Feb; 175 Suppl 1():S247-53. PubMed ID: 9203724
[TBL] [Abstract][Full Text] [Related]
12. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
Friedrich F
Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of rinderpest vaccine by modification of the lyophilization process.
House JA; Mariner JC
Dev Biol Stand; 1996; 87():235-44. PubMed ID: 8854023
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cells.
Mallet L; Pelloquin F; Brigaud M; Caudrelier P; Bandet R; Xueref C; Fuchs F; Gibelin N; Goldman C; Moulin JC; de Fraipont F; Montagnon B; Peyron L; Aymard M
J Med Virol; 1997 May; 52(1):50-60. PubMed ID: 9131458
[TBL] [Abstract][Full Text] [Related]
15. Polio eradication: the OPV paradox.
Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ
Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339
[TBL] [Abstract][Full Text] [Related]
16. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
17. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
Yang C; Shi H; Zhou J; Liang Y; Xu H
Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
[TBL] [Abstract][Full Text] [Related]
18. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.
Thys B; De Palma AM; Neyts J; Andries K; Vrijsen R; Rombaut B
Antiviral Res; 2008 Jun; 78(3):278-81. PubMed ID: 18294707
[TBL] [Abstract][Full Text] [Related]
19. [Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].
Delpeyroux F; Guillot S; Szendröi A; Balanant J; Caro V; Cuervo N; Chevaliez S; Dahourou G; Crainic R
Bull Soc Pathol Exot; 2000 Jul; 93(3):193-7. PubMed ID: 11030056
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
